Lotus Pharmaceutical (1795.TW) Q4 2023 Earnings

15MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
1.52
2.5
3.48
4.46

Details

Expected EPS
1.5174176522736
Actual EPS
1.575067169592
Surprise EPS
0.06
Surprise Percent
+3.8%

Description

Lotus Pharmaceutical (1795.TW) has reported earnings of 1.575067169592 per share for Q4 2023.

0 Comments

Share your thoughts